Comparative Pharmacology
Head-to-head clinical analysis: BETADINE versus CIDA STAT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BETADINE versus CIDA STAT.
BETADINE vs CIDA-STAT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Povidone-iodine is an iodophor that releases free iodine, which oxidizes and iodinates microbial proteins and enzymes, leading to rapid broad-spectrum microbicidal activity against bacteria, fungi, viruses, and protozoa.
CIDA-STAT is a hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor that competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to increased hepatic LDL receptor expression and reduced plasma LDL cholesterol levels.
Apply topically as a 10% povidone-iodine solution to the affected area 1-3 times daily; for preoperative skin preparation, apply as a single scrub for 5 minutes; for mouthwash/gargle, use 1% solution (diluted 1:10) 4 times daily; for vaginal use, 10% solution as a douche once daily. Not for systemic use.
10 mg orally once daily
None Documented
None Documented
2-7 days for iodine, prolonged in renal impairment; clinical context: topical use has minimal systemic absorption.
Terminal half-life: 12-15 hours; requires dose adjustment in renal impairment (CrCl <30 mL/min)
Renal: >90% as iodide; biliary/fecal <10%.
Renal: 30% unchanged; Biliary/fecal: 60% as metabolites; 10% other
Category C
Category C
Antiseptic
Antiseptic